New Abbott HIV Test Can Detect HIV Days Earlier than Current US Tests
Abbott’s ARCHITECT HIV Ag/Ab Combo assay is the first test approved in the United States that can simultaneously detect both HIV antigen and antibodies.
Read MorePosted by Clinical Lab Products | Jun 23, 2010 | Sexually Transmitted Diseases |
Abbott’s ARCHITECT HIV Ag/Ab Combo assay is the first test approved in the United States that can simultaneously detect both HIV antigen and antibodies.
Read MorePosted by Clinical Lab Products | Jun 22, 2010 | Cancer, Miscellaneous |
US Department of Health and Human Services Secretary Kathleen Sebelius today announced $250 million in new Affordable Care Act investments to support prevention activities and develop the nations public health infrastructure.
Read MorePosted by Clinical Lab Products | Jun 18, 2010 | Miscellaneous, Osteoporosis |
QIAGEN has announced that it has entered into an agreement with the Dutch molecular diagnostic component supplier Genome Diagnostics which covers the development and commercialization of 6 new tests until 2011.
Read MorePosted by Clinical Lab Products | Jun 15, 2010 | Sepsis |
In the June Anesthesiology researchers take aim at identifying genetic risk factors for sepsis a leading cause of death for critically ill patients.
Read MorePosted by Clinical Lab Products | Jun 7, 2010 | Miscellaneous |
FDA Grants Quest Diagnostics Simplexa 2009 H1N1 Test 501(k) Clearance Quest Diagnostics Inc has announced that the FDA has issued 510(k) clearance to the Simplexa™ Influenza A H1N1 (2009) test on the 3M™ integrated cycler. The Simplexa test,
Read More